BioCryst has acquired 2 companies. A total of 2 acquisitions came from private equity firms.
BioCryst’s largest acquisition to date was in 2012, when it acquired Presidio Pharmaceuticals for $101M. BioCryst has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to BioCryst’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2